Cryonove Pharma
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2039
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 22, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 24, 2026
- Oct 27 US 12,773,252 Cosmetic Composition Intended for the Treatment of Skin Hyperpigmentation and Treatment Method Using Said Composition
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 3 of 3
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,452,026 | Method and Device for Transmitting Data by Means of Wireless Backhaul Network In force · High confidence | In force | High confidence | |
| US 11,589,911 | Application Nozzle for a Device for the Dermo-Cosmetic Treatment of Dark Skin Spots by Cyto-Selective Cryotherapy In force · High confidence | In force | High confidence | |
| US 12,773,252 | Cosmetic Composition Intended for the Treatment of Skin Hyperpigmentation and Treatment Method Using Said Composition In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.